Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alex Rubinsteyn

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|March 4, 2020
OpenVax: An Open-Source Computational Pipeline for Cancer Neoantigen PredictionJulia Kodysh, Alex Rubinsteyn
Methods in Molecular Biology (Clifton, N.J.)|March 4, 2020
High-Throughput MHC I Ligand Prediction Using MHCflurryTimothy O'Donnell, Alex Rubinsteyn
Cell Systems|July 27, 2020
MHCflurry 2.0: Improved Pan-Allele Prediction of MHC Class I-Presented Peptides by Incorporating Antigen ProcessingTimothy J O'Donnell, Alex Rubinsteyn, Uri Laserson
Cell Systems|October 22, 2020
MHCflurry 2.0: Improved Pan-Allele Prediction of MHC Class I-Presented Peptides by Incorporating Antigen ProcessingTimothy J O'Donnell, Alex Rubinsteyn, Uri Laserson
Oncology (Williston Park, N.Y.)|December 18, 2015
Mutation-Derived Tumor Antigens: Novel Targets in Cancer ImmunotherapyJohn P Finnigan, Alex Rubinsteyn, Jeffrey Hammerbacher, et al.
Progress in Molecular Biology and Translational Science|August 7, 2019
Bioinformatic methods for cancer neoantigen predictionSebastian Boegel, John C Castle, Julia Kodysh, et al.
Briefings in Bioinformatics|January 5, 2024
ACE configurator for ELISpot: optimizing combinatorial design of pooled ELISpot assays with an epitope similarity modelJin Seok Lee, Dhuvarakesh Karthikeyan, Misha Fini, et al.
Cell Systems|July 2, 2018
MHCflurry: Open-Source Class I MHC Binding Affinity PredictionTimothy J O'Donnell, Alex Rubinsteyn, Maria Bonsack, et al.
Nature Machine Intelligence|September 29, 2025
Conditional generation of real antigen-specific T cell receptor sequencesDhuvarakesh Karthikeyan, Sarah N Bennett, Amy G Reynolds, et al.
Frontiers in Immunology|February 7, 2018
Computational Pipeline for the PGV-001 Neoantigen Vaccine TrialAlex Rubinsteyn, Julia Kodysh, Isaac Hodes, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Methods in Molecular Biology (Clifton, N.J.)|March 4, 2020
OpenVax: An Open-Source Computational Pipeline for Cancer Neoantigen PredictionJulia Kodysh, Alex Rubinsteyn
Methods in Molecular Biology (Clifton, N.J.)|March 4, 2020
High-Throughput MHC I Ligand Prediction Using MHCflurryTimothy O'Donnell, Alex Rubinsteyn
Cell Systems|July 27, 2020
MHCflurry 2.0: Improved Pan-Allele Prediction of MHC Class I-Presented Peptides by Incorporating Antigen ProcessingTimothy J O'Donnell, Alex Rubinsteyn, Uri Laserson
Cell Systems|October 22, 2020
MHCflurry 2.0: Improved Pan-Allele Prediction of MHC Class I-Presented Peptides by Incorporating Antigen ProcessingTimothy J O'Donnell, Alex Rubinsteyn, Uri Laserson
Oncology (Williston Park, N.Y.)|December 18, 2015
Mutation-Derived Tumor Antigens: Novel Targets in Cancer ImmunotherapyJohn P Finnigan, Alex Rubinsteyn, Jeffrey Hammerbacher, et al.
Progress in Molecular Biology and Translational Science|August 7, 2019
Bioinformatic methods for cancer neoantigen predictionSebastian Boegel, John C Castle, Julia Kodysh, et al.
Briefings in Bioinformatics|January 5, 2024
ACE configurator for ELISpot: optimizing combinatorial design of pooled ELISpot assays with an epitope similarity modelJin Seok Lee, Dhuvarakesh Karthikeyan, Misha Fini, et al.
Cell Systems|July 2, 2018
MHCflurry: Open-Source Class I MHC Binding Affinity PredictionTimothy J O'Donnell, Alex Rubinsteyn, Maria Bonsack, et al.
Nature Machine Intelligence|September 29, 2025
Conditional generation of real antigen-specific T cell receptor sequencesDhuvarakesh Karthikeyan, Sarah N Bennett, Amy G Reynolds, et al.
Frontiers in Immunology|February 7, 2018
Computational Pipeline for the PGV-001 Neoantigen Vaccine TrialAlex Rubinsteyn, Julia Kodysh, Isaac Hodes, et al.
Pageof 2